Brie Carter

MediciNova (NASDAQ:MNOV), the La Jolla-based biopharmaceutical firm, released its fourth-quarter and full-year 2025 financial results on Friday, February 20, 2026.

Hudbay Minerals (NYSE:HBM), the Toronto-based diversified miner, reported a landmark fiscal 2025 on Friday, delivering record financial results and achieving all major production targets despite a year marked by wildfire-related disruptions in Canada and operational shifts in Peru.

AbbVie (NYSE:ABBV) announced on February 20, 2026, that the U.S. Food and Drug Administration (FDA), has approved the combination of VENCLEXTA (venetoclax) and acalabrutinib for adult patients with previously untreated chronic lymphocytic leukemia (CLL).

AI agents may not yet be cost-effective enough to replace human workers, according to tech investors who say usage fees and maintenance can exceed traditional salary costs.

Bitcoin’s recent 46% slide from its October peak is unlikely to be driven by fears over quantum computing, according to developer Matt Carallo, who argued that Ether’s weak performance undermines that narrative.

Top institutional holders increased their stakes in Bitmine Immersion Technologies during the fourth quarter of 2025 despite a sharp sell-off, signalling sustained Wall Street demand for the largest corporate Ethereum treasury vehicle.

US spot Bitcoin exchange-traded funds still hold about $53 billion in cumulative net inflows despite recent heavy redemptions, according to Eric Balchunas.

CME Group will launch 24/7 trading for its regulated cryptocurrency futures and options from 4 p.m. CT on May 29, pending regulatory approval, marking a structural shift in traditional derivatives market access to digital assets.

Gold mining giant Newmont (ASX:NEM) has delivered a sound fiscal year 2025, reporting a 112% surge in net income to $7.09 billion.

Megaport (ASX:MP1) said group annual recurring revenue jumped 49% year-over-year to $338 million for the half year to Dec. 31, 2025.